Bridgeway Capital Management »

Prelude Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $586k 124k 4.74
2023-09-30 $114k 37k 3.09
2023-06-30 $166k 37k 4.50
2023-03-31 $211k 37k 5.70
2022-12-31 $223k 37k 6.04
2022-09-30 $244k 37k 6.60
2022-06-30 $245k 47k 5.22